Podium presentation from Dr. David Johnson at the 2023 In Vivo Cell Engineering conference

GigaMune Founder & CEO David Johnson spoke at the 2023 In Vivo Cell Engineering Conference, held in Boston in July 2023. Dr. Johnson described GigaMune’s recent advances in developing a large panel of viral pseudotypes for engineering virus-like particles to deliver genes to various kinds of immune cells. The conference included experts from Capstan, Sana, Interius, and other industry leading companies working in the field of in vivo cell engineering.